Anti-IL-20 monoclonal antibody suppresses prostate cancer growth and bone osteolysis in murine models

Agriculture & Biology

• bone resorption 84%
• prostatic neoplasms 82%
• interleukins 72%
• monoclonal antibodies 54%
• animal models 53%
• bones 51%
• neoplasms 25%
• neoplasm cells 24%
• cathepsin K 11%
• cathepsin G 10%
• urinary bladder neoplasms 10%
• bone density 9%
• cadherins 9%
• vimentin 8%
• interleukin-10 8%
• fibronectins 7%
• breast neoplasms 7%
• cell movement 7%
• cytokines 6%
• pathogenesis 6%
• cell lines 5%
• staining 5%
• injection 4%
• receptors 4%
• mice 3%
• tissues 3%
• cells 2%

Medicine & Life Sciences

• interleukin 20 100%
• Bone Neoplasms 74%
• Osteolysis 73%
• Prostatic Neoplasms 48%
• Monoclonal Antibodies 44%
• Growth 30%
• Neoplasms 17%
• interleukin-20 receptor 14%
• Prostate 12%
• Cathepsin G 11%
• Cathepsin K 10%
• PC-3 Cells 9%
• SCID Mice 8%
• Mouth Neoplasms 8%
• Vimentin 7%
• Cadherins 7%
• Fibronectins 7%
• Urinary Bladder Neoplasms 7%
• Bone Density 6%
• Heterografts 6%
• Interleukin-10 6%
• Cell Movement 6%
• Staining and Labeling 4%
• Breast Neoplasms 4%
• Cytokines 4%
• Cell Line 4%
• Injections 4%
• In Vitro Techniques 3%

Chemical Compounds

• Fibronectin 73%